Todd Pope - 12 Jun 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Reporting relationship: Director
Issuer ticker: HUMA
Reported as of: 12 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2025, 16:32:48 UTC
Prior SEC filing: 17 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Todd Pope by Dale A. Sander as Attorney-in-Fact

Key filing fact

Todd Pope filed Form 4 for Humacyte, Inc. (HUMA) on 16 Jun 2025.

Key facts

This page summarizes Todd Pope's Form 4 filing for Humacyte, Inc. (HUMA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2025, 16:32.

Change

Previous filing in this sequence was filed on 17 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001584367 Primary reporting owner

Pope Todd

Relationship: Director
Address: 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Signature: /s/ Todd Pope by Dale A. Sander as Attorney-in-Fact
Signature date: 16 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUMA transaction Derivative

Stock Options (right to buy)

Award

Transaction value: $0
Shares: +80,000
Change %
Price: $0.000000
Shares after: 80,000
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 80,000
Exercise price: $2.41
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.